Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts



Related Series

Speech Recognition (Front-End EMR) Segment Highlight 2020
Front-End Speech 2018
Front-End Speech
Front-End Speech 2014
Speech Recognition 2013
Speech Recognition 2010
Speech Recognition 2007
Speech Recognition Report 2006

 End chart zoom
Speech Recognition 2008 Speech Recognition 2008
* A page refresh may be necessary to see the updated image

Speech Recognition 2008

July 1, 2008

In recent years, healthcare provider organizations have reported dramatic workflow efficiency and cost savings benefits by adopting speech recognition technology. These reports have motivated a great many providers to consider speech recognition as the next step in automating their data flow and documentation; that movement toward automation prompted this study on the vendors that supply speech recognition technology.

KLAS interviewed more than 300 individual healthcare professionals regarding the speech recognition solutions in use at their respective organizations for this 307 page report.

Front-end speech recognition products qualifying for ranking in the study were:

  • Agfa TalkStation
  • MedQuist SpeechQ
  • Nuance PowerScribe
  • Nuance RadWhere (Commissure)
    • Back-end speech recognition products qualifying for ranking in the study were:

      • eScription EditScript (now Nuance)
      • Dolbey Fusion Speech
      • Nuance EXSpeech (Dictaphone)

      Early back-end speech recognition findings were also included for MedQuist DocQment.

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.